Sign Out
150 mg: The solution is colourless to yellow and clear to slightly opalescent.
Each pre-filled pen contains 150 mg risankizumab in 1 mL solution.
360 mg: The solution is colourless to yellow and clear to slightly opalescent.
Each cartridge contains 360 mg of risankizumab in 2.4 mL solution.
Excipients with known effect: This medicinal product contains 0.48 mg of polysorbate 20 in each 360 mg dose.
600 mg: The solution is colourless to slightly yellow and clear to slightly opalescent.
Each vial contains 600 mg of risankizumab in 10.0 mL of solution.
Excipients with known effect: This medicinal product contains 2 mg of polysorbate 20 in each 600 mg dose.
Risankizumab is a humanised immunoglobulin G1 (IgG1) monoclonal antibody selective to the interleukin (IL)-23 protein produced in Chinese Hamster Ovary cells using recombinant DNA technology.
Excipients/Inactive Ingredients: Sodium acetate trihydrate, Acetic acid, Trehalose dihydrate, Polysorbate 20, Water for injections.
Continue with Google